HK1148348A1 - Automated enumeration and characterization of circulating melanoma cells in blood - Google Patents

Automated enumeration and characterization of circulating melanoma cells in blood

Info

Publication number
HK1148348A1
HK1148348A1 HK11102264.2A HK11102264A HK1148348A1 HK 1148348 A1 HK1148348 A1 HK 1148348A1 HK 11102264 A HK11102264 A HK 11102264A HK 1148348 A1 HK1148348 A1 HK 1148348A1
Authority
HK
Hong Kong
Prior art keywords
characterization
blood
melanoma cells
circulating melanoma
automated enumeration
Prior art date
Application number
HK11102264.2A
Other languages
English (en)
Chinese (zh)
Inventor
Mark Carle Connelly
Galla Chandra Rao
Leon Wmm Terstappen
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Publication of HK1148348A1 publication Critical patent/HK1148348A1/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/5743Specifically defined cancers of skin, e.g. melanoma
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70589CD45
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK11102264.2A 2007-11-27 2011-03-07 Automated enumeration and characterization of circulating melanoma cells in blood HK1148348A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US434507P 2007-11-27 2007-11-27
PCT/US2008/080436 WO2009070392A1 (en) 2007-11-27 2008-10-20 Automated enumeration and characterization of circulating melanoma cells in blood

Publications (1)

Publication Number Publication Date
HK1148348A1 true HK1148348A1 (en) 2011-09-02

Family

ID=40670042

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11102062.6A HK1148068A1 (en) 2007-11-27 2011-03-01 Automated enumeration and characterization of circulating melanoma cells in blood
HK11102264.2A HK1148348A1 (en) 2007-11-27 2011-03-07 Automated enumeration and characterization of circulating melanoma cells in blood

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK11102062.6A HK1148068A1 (en) 2007-11-27 2011-03-01 Automated enumeration and characterization of circulating melanoma cells in blood

Country Status (12)

Country Link
US (1) US20090136946A1 (xx)
EP (1) EP2225563B1 (xx)
JP (1) JP5479355B2 (xx)
KR (1) KR101604649B1 (xx)
CN (1) CN101878429B (xx)
BR (1) BRPI0819854B1 (xx)
CA (1) CA2706442C (xx)
DK (1) DK2225563T3 (xx)
HK (2) HK1148068A1 (xx)
IL (1) IL205864A (xx)
MX (1) MX2010005811A (xx)
WO (1) WO2009070392A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010068812A1 (en) 2008-12-10 2010-06-17 Abqmr, Inc. Nuclear magnetic resonance apparatus, methods and associated technology
WO2010151109A1 (en) * 2009-06-26 2010-12-29 Erasmus University Medical Center Rotterdam Identifying circulating tumor cells (ctcs) using cd146 in breast cancers patients
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
TWI539158B (zh) * 2010-06-08 2016-06-21 維里德克斯有限責任公司 使用血液中之循環黑色素瘤細胞預測黑色素瘤病患之臨床結果的方法。
US9618515B2 (en) * 2011-07-21 2017-04-11 Janssen Diagnostics, Llc Assay to capture and detect circulating multiple myeloma cells from blood
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
PL2972359T3 (pl) 2013-03-15 2021-03-08 Menarini Silicon Biosystems S.P.A. Wzbogacanie krążących komórek nowotworowych poprzez deplecję białych krwinek
CN103472227A (zh) * 2013-09-18 2013-12-25 上海卫恒医疗器械有限公司 一种循环肿瘤细胞检测试剂盒、配套仪器及应用
WO2016191532A1 (en) 2015-05-26 2016-12-01 Creatv Microtech Inc. Use of circulating tumor cell mitotic index in cancer stratification and diagnostics

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
DE19736691A1 (de) * 1997-08-22 1999-02-25 Michael Prof Dr Med Giesing Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen
EP1030675B1 (en) * 1997-11-14 2009-08-12 The General Hospital Corporation Treatment of hematologic disorders
KR100399475B1 (ko) * 1998-02-12 2003-09-29 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 순환 중인 암세포의 신속하고 효과적인 분리 방법 및 이를위한 제제
US20010018192A1 (en) * 1998-02-12 2001-08-30 Terstappen Leon W.M.M. Labeled cells for use as an internal functional control in rare cell detection assays
US7029652B2 (en) * 1998-09-16 2006-04-18 The Regents Of The University Of California Method of treating tumors
US6551843B1 (en) * 1999-01-29 2003-04-22 Immunivest Corporation Methods for enhancing binding interactions between members of specific binding pairs
US6222096B1 (en) * 1999-03-01 2001-04-24 Stine Biotechnology Promoter and construct for plant transformation
US6623982B1 (en) * 1999-07-12 2003-09-23 Immunivest Corporation Increased separation efficiency via controlled aggregation of magnetic nanoparticles
CA2378182C (en) * 1999-07-28 2014-09-23 Genentech, Inc. Compositions and methods for the treatment of tumors
CA2404431C (en) * 2000-03-27 2011-06-07 Thomas Jefferson University Guanylyl cyclase c in the detection of stomach and esophageal cancers
AU2002218450A1 (en) * 2000-10-13 2002-04-22 Norwood Immunology Ltd Diagnostic indicator of thymic function
US7223596B2 (en) * 2003-09-05 2007-05-29 Wisconsin Alumni Research Foundation Malignant endothelial cell line and uses thereof in models for angiogenesis
WO2006130737A1 (en) * 2005-06-02 2006-12-07 Immunivest Corporation A method for assessing metastatic carcinomas from circulating endothelial cells and disseminated tumor cells
US20070037173A1 (en) * 2005-08-12 2007-02-15 Allard Jeffrey W Circulating tumor cells (CTC's): early assessment of time to progression, survival and response to therapy in metastatic cancer patients

Also Published As

Publication number Publication date
IL205864A0 (en) 2010-11-30
DK2225563T3 (en) 2015-02-09
EP2225563B1 (en) 2015-01-21
HK1148068A1 (en) 2011-08-26
IL205864A (en) 2016-12-29
KR20100101109A (ko) 2010-09-16
EP2225563A4 (en) 2011-11-16
CA2706442C (en) 2017-07-11
KR101604649B1 (ko) 2016-03-18
US20090136946A1 (en) 2009-05-28
EP2225563A1 (en) 2010-09-08
MX2010005811A (es) 2010-06-09
CN101878429A (zh) 2010-11-03
JP2011505012A (ja) 2011-02-17
CA2706442A1 (en) 2009-06-04
BRPI0819854A2 (pt) 2015-06-16
BRPI0819854B1 (pt) 2019-06-04
WO2009070392A1 (en) 2009-06-04
JP5479355B2 (ja) 2014-04-23
CN101878429B (zh) 2015-05-20

Similar Documents

Publication Publication Date Title
HK1148348A1 (en) Automated enumeration and characterization of circulating melanoma cells in blood
HK1245147A1 (zh) 激活素-actrii的拮抗劑及在提高紅細胞水平中的用途
HK1216261A1 (zh) 低溫和/或低 值在細胞培養中的使用
HK1138374A1 (en) Methods of evaluating cells and cell cultures
EP2376920A4 (en) METHOD FOR DETECTING CHANGES IN CELLS
AP3322A (en) Cell assay kit and method
EP2181482A4 (en) DESIGNING A BATTERY ELEMENT AND METHODS FOR ITS CONSTRUCTION
PT2170316E (pt) Melhoramento de memória em indivíduos com exame de estado mini mental de 24-26
PL3323883T3 (pl) Zdefiniowane powierzchnie do hodowli komórkowej i sposoby użycia
ZA200908904B (en) Multipotent/pluripotent cells and methods
EP2480688A4 (en) METHOD AND TESTS FOR DETECTING THE ACTIVITY OF THE ALT MECHANISM OF TELOMERS IN CELLS
EP2257155A4 (en) KRYOCONSERVATION OF BIOLOGICAL CELLS AND TISSUE
IL200161A0 (en) Method for activation of helper t cell and composition for use in the method
PL2170349T3 (pl) Leczenie wad serca u ssaków innych niż człowiek antagonistą aldosteronu
EP2154745A4 (en) FUEL CELL OF POLYELECTROLYTTYPE AND VOLTAGE MEASURING METHOD OF A CELL IN IT
GB0901605D0 (en) Back contacting and interconnection of two solar cells
GB2450337B (en) Cell culture and mixing vessel
ZA201101137B (en) Prf in cell and tissue culture
EP2115127A4 (en) METHOD AND COMPOSITIONS FOR IMPROVING CELL HEALTH IN CULTURES
PL2318020T3 (pl) Immunosupresyjne komórki krwi i sposób ich wytwarzania
EP2318570A4 (en) ELECTROLYTIC CELL AND RELATED METHODS FOR THE PRODUCTION AND USE THEREOF
EP2276857A4 (en) AFFECTED ALLELES OF GENES INVOLVED IN METABOLISM TRANSACTIONS AND METHOD OF IDENTIFICATION AND USE THEREOF
PL386772A1 (pl) Sposób wykrywania komórek czerniaka w preparatach parafinowych
HU0600082D0 (en) Process and testset for examination of the metabolic state of the organism in connection with carbohydrate - and fatmetabolism
GB0819611D0 (en) Electrochemical cells and components thereof